Nipro Corporation (8086.T) Bundle
Curious who's backing Nipro Corporation (8086.T) and what that vote of confidence means for the stock? Institutional investors control a notable 28.76% of shares, led by Japan Trustee Services Bank, Ltd. at 10.0% after a +2.0% quarterly bump, while BlackRock Fund Advisors holds 5.0% (with BlackRock Inc. reported near 5.2% overall after buying 1.2 million shares) and State Street Global Advisors trimmed its stake to 6.0% following a -1.5% reduction; other players include Invesco at 4.0%, Nippon Life at 3.0%, Vanguard (~4.8%), Sumitomo Mitsui Trust (~3.5%) and Wellington (~3.2%, which added ~500,000 shares). On market metrics, Nipro's market cap stood at ¥236.81 billion (Dec 9, 2025), the stock is up 7.17% over 52 weeks with a -0.04 beta, a trailing P/E of 25.00 and forward P/E of 17.92, a dividend yield of 1.79% (ex-dividend March 28, 2025), and a 52-week range of ¥1,230.50-¥1,572.00-read on to see which investors' moves matter most and why those shifts could reshape Nipro's trajectory
Nipro Corporation (8086.T) - Who Invests in Nipro Corporation (8086.T) and Why?
Institutional investors are prominent holders of Nipro Corporation (8086.T), reflecting market confidence in its medical-device and healthcare-related businesses, steady cash flow from dialysis and pharmaceutical packaging, and exposure to aging-population demand in Japan and abroad. Key motives cited by large holders include defensible recurring-revenue segments, margin recovery from cost controls, and strategic international expansion.- Portfolio diversification into healthcare and medical devices to hedge demographic risks.
- Long-term income and dividend potential from stable business lines (dialysis consumables, pharmaceutical packaging).
- Exposure to growth from global medical-device demand and M&A-driven scale.
| Investor | Reported Stake / Position | Recent Change | Implied Rationale |
|---|---|---|---|
| BlackRock Fund Advisors | 5.0% | No recent change disclosed publicly | Large passive/active allocation to healthcare; conviction in long-term growth |
| Invesco Ltd. | 4.0% | No recent change disclosed publicly | Strategic growth exposure; tactical overweight to medical sector |
| Nippon Life Insurance Company | 3.0% | No recent change disclosed publicly | Long-duration institutional holding for stable returns |
| Japan Trustee Services Bank, Ltd. | Varies by account; trustee holdings substantial | Increased stake by 2.0% in the last quarter | Positive outlook on near-term growth potential and dividend prospects |
| State Street Global Advisors | Significant index/ETF-related holdings | Reduced holding by 1.5% | Portfolio rebalancing or shifting ETF/index weights |
- High institutional ownership typically reduces free-float volatility but can amplify moves when large holders rebalance.
- Positive stake increases (e.g., Japan Trustee Services Bank, Ltd. +2.0%) signal conviction that can attract other fiduciaries.
- Reductions by major index managers (e.g., State Street -1.5%) often reflect index weight changes rather than company-specific negative views.
- Stable recurring revenue from dialysis and pharmaceutical packaging.
- Margin-improvement programs and efficiency gains after restructuring.
- Growth from overseas markets and targeted acquisitions expanding product mix.
- Defensive sector status amid macro uncertainty-healthcare demand remains resilient.
Nipro Corporation (8086.T) - Institutional Ownership and Major Shareholders of Nipro Corporation (8086.T)
Nipro Corporation (8086.T) shows concentrated institutional interest with 28.76% of shares held by institutions. Major shareholders include a mix of domestic Japanese trustees and global asset managers; recent quarter-to-quarter shifts indicate active portfolio rebalancing by those investors, which can affect liquidity, governance influence, and stock demand dynamics.- Japan Trustee Services Bank, Ltd. - 10.0% ownership; +2.0% QoQ
- State Street Global Advisors - 6.0% ownership; -1.5% QoQ
- BlackRock Fund Advisors - 5.0% ownership; +1.0% QoQ
- Invesco Ltd. - 4.0% ownership; +0.5% QoQ
- Nippon Life Insurance Company - 3.0% ownership; -0.5% QoQ
| Holder | Ownership (%) | Quarterly Change (ppt) | Notes |
|---|---|---|---|
| Japan Trustee Services Bank, Ltd. | 10.0 | +2.0 | Largest single institutional holder; likely holds shares for multiple retail/benefit plans. |
| State Street Global Advisors | 6.0 | -1.5 | Significant passive/ETF exposure; pullback suggests reweighting. |
| BlackRock Fund Advisors | 5.0 | +1.0 | Growing allocation consistent with active/passive strategies. |
| Invesco Ltd. | 4.0 | +0.5 | Incremental accumulation; may reflect thematic exposure to healthcare devices/pharma supply chain. |
| Nippon Life Insurance Company | 3.0 | -0.5 | Domestic insurer reducing exposure slightly. |
| Total Institutional Ownership | 28.76% - meaningful institutional stake influencing governance and trading flows | ||
- High trustee ownership (Japan Trustee Services Bank) often reflects concentrated nominee holdings for retail/defined-benefit accounts - can create stability but also block voting influence.
- Large global asset managers (State Street, BlackRock, Invesco) collectively represent 15.0% - their ETF/passive flows can amplify price moves during index rebalances.
- Quarterly shifts (both buys and sells) signal active rebalancing: a net increase among global managers partially offsets reductions by some domestic holders.
Nipro Corporation (8086.T) Key Investors and Their Impact on Nipro Corporation (8086.T)
Nipro Corporation (8086.T) has attracted significant institutional interest, with a concentrated ownership base among global asset managers and domestic trust banks. The positions below reflect reported stakes and recent trading activity that help explain market sentiment and potential governance implications.- BlackRock Inc. - ~5.2% ownership; increased position by ~1.2 million shares in the last quarter, signaling renewed conviction in growth and scale benefits from global healthcare demand.
- The Vanguard Group - ~4.8% ownership; a steady, sizable passive/index-based holding consistent with long-term confidence in Nipro's fundamentals.
- Sumitomo Mitsui Trust Holdings - ~3.5% ownership; a domestic institutional holder reflecting local investor endorsement of corporate strategy and governance.
- Wellington Management - ~3.2% ownership; added approximately 500,000 shares recently, suggesting an active tactical bet on market expansion initiatives.
| Investor | Approx. Ownership (%) | Recent Share Change | Investment Signal |
|---|---|---|---|
| BlackRock Inc. | 5.2% | +1,200,000 shares (last quarter) | Confidence in growth trajectory; potential influence on proxy matters |
| The Vanguard Group | 4.8% | Stable / passive holding | Long-term indexing support; less likely to engage activist strategies |
| Sumitomo Mitsui Trust Holdings | 3.5% | Stable | Domestic institutional backing; aligned with local governance expectations |
| Wellington Management | 3.2% | +500,000 shares (recent) | Active accumulation tied to market expansion thesis |
- Strategic stability: Large passive holders (Vanguard, BlackRock) provide capital stability and lower short-term volatility risk.
- Active engagement potential: BlackRock's recent build and Wellington's purchases increase the chance of engagement on strategy, capital allocation, and M&A.
- Domestic support: Sumitomo Mitsui Trust's stake strengthens alignment with local regulatory and stakeholder expectations.
- Market signaling: The combination of increased positions and substantial baseline ownership percentages contributes to positive investor sentiment and may support tighter valuation multiples relative to peers.
Nipro Corporation (8086.T) - Market Impact and Investor Sentiment
Nipro Corporation (8086.T) shows signs of stable investor confidence and measured growth appeal among income and growth-focused investors. Key market metrics through December 9, 2025, illustrate valuation, volatility, and shareholder return characteristics that drive buying decisions.
- Market capitalization: ¥236.81 billion (Dec 9, 2025)
- 52-week price change: +7.17%
- Beta: -0.04 (low correlation/volatility relative to benchmark)
- Trailing P/E: 25.00; Forward P/E: 17.92
- Dividend yield: 1.79% (ex-dividend date: March 28, 2025)
- 52-week price range: ¥1,230.50 - ¥1,572.00
| Metric | Value | Interpretation |
|---|---|---|
| Market Cap | ¥236.81 billion | Mid-cap, reflects investor confidence and liquidity |
| 52-Week Change | +7.17% | Positive momentum over one year |
| Beta | -0.04 | Very low volatility; slight negative correlation vs. market |
| Trailing P/E | 25.00 | Moderate valuation based on last 12 months earnings |
| Forward P/E | 17.92 | Market expects earnings growth or re-rating |
| Dividend Yield | 1.79% | Provides modest income to shareholders |
| Ex-Dividend Date | March 28, 2025 | Reference point for dividend eligibility |
| 52-Week Range | ¥1,230.50 - ¥1,572.00 | Relatively narrow range, indicating stable performance |
Investor composition and sentiment drivers:
- Institutional investors: favor stable earnings and moderate yield; attracted by forward P/E near 18 and predictable cash flows.
- Dividend/income investors: value the 1.79% yield as part of a diversified income sleeve, noting the March 28, 2025 ex-dividend date for record planning.
- Value/growth investors: interpret the drop from trailing to forward P/E as either expected earnings improvement or market re-rating opportunity.
- Defensive allocators: low beta (-0.04) makes Nipro suitable for portfolios reducing market correlation risk.
- Short-term traders: 52-week range and modest upward momentum (+7.17%) offer limited but present upside; volatility is muted.
Relevant corporate context and reference: Mission Statement, Vision, & Core Values (2026) of Nipro Corporation.
Nipro Corporation (8086.T) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.